Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Two ribosome recruitment sites direct multiple translation events within HIV1 Gag open reading frame.

Deforges J, de Breyne S, Ameur M, Ulryck N, Chamond N, Saaidi A, Ponty Y, Ohlmann T, Sargueil B.

Nucleic Acids Res. 2017 Jul 7;45(12):7382-7400. doi: 10.1093/nar/gkx303.

2.

Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.

Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, Capoferri AA, Beg SA, Huang SH, Karandish S, Hao H, Halper-Stromberg E, Yong PC, Kovacs C, Benko E, Siliciano RF, Ho YC.

Cell Host Microbe. 2017 Apr 12;21(4):494-506.e4. doi: 10.1016/j.chom.2017.03.008.

PMID:
28407485
3.

Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic.

Cassan E, Arigon-Chifolleau AM, Mesnard JM, Gross A, Gascuel O.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11537-11542. Epub 2016 Sep 28.

4.

Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli.

Prasad S, Starck SR, Shastri N.

J Immunol. 2016 Oct 15;197(8):2981-2991. Epub 2016 Sep 19.

5.

Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.

Starck SR, Shastri N.

Immunol Rev. 2016 Jul;272(1):8-16. doi: 10.1111/imr.12434. Review.

6.

Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs.

Yang N, Gibbs JS, Hickman HD, Reynoso GV, Ghosh AK, Bennink JR, Yewdell JW.

J Immunol. 2016 May 1;196(9):3608-17. doi: 10.4049/jimmunol.1502303. Epub 2016 Mar 25.

7.

Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Spencer CT, Bezbradica JS, Ramos MG, Arico CD, Conant SB, Gilchuk P, Gray JJ, Zheng M, Niu X, Hildebrand W, Link AJ, Joyce S.

Proteomics Clin Appl. 2015 Dec;9(11-12):1035-52. doi: 10.1002/prca.201500106.

8.

Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Bansal A, Mann T, Sterrett S, Peng BJ, Bet A, Carlson JM, Goepfert PA.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):1-8. doi: 10.1097/QAI.0000000000000700.

9.

The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.

Bet A, Maze EA, Bansal A, Sterrett S, Gross A, Graff-Dubois S, Samri A, Guihot A, Katlama C, Theodorou I, Mesnard JM, Moris A, Goepfert PA, Cardinaud S.

Retrovirology. 2015 Feb 10;12:15. doi: 10.1186/s12977-015-0135-y.

10.

Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Gilchuk P, Hill TM, Wilson JT, Joyce S.

Curr Opin Immunol. 2015 Jun;34:43-51. doi: 10.1016/j.coi.2015.01.013. Epub 2015 Feb 6. Review.

11.

Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.

Rucevic M, Boucau J, Dinter J, Kourjian G, Le Gall S.

Viruses. 2014 Aug 21;6(8):3271-92. doi: 10.3390/v6083271. Review.

12.

Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccine.

Bet A, Sterrett S, Sato A, Bansal A, Goepfert PA.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):142-50. doi: 10.1097/QAI.0b013e3182a9917e.

13.

HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Boucherma R, Kridane-Miledi H, Bouziat R, Rasmussen M, Gatard T, Langa-Vives F, Lemercier B, Lim A, BĂ©rard M, Benmohamed L, Buus S, Rooke R, Lemonnier FA.

J Immunol. 2013 Jul 15;191(2):583-93. doi: 10.4049/jimmunol.1300483. Epub 2013 Jun 17.

14.

Acute phase CD8+ T lymphocytes against alternate reading frame epitopes select for rapid viral escape during SIV infection.

Walsh AD, Bimber BN, Das A, Piaskowski SM, Rakasz EG, Bean AT, Mudd PA, Ericsen AJ, Wilson NA, Hughes AL, O'Connor DH, Maness NJ.

PLoS One. 2013 May 6;8(5):e61383. doi: 10.1371/journal.pone.0061383. Print 2013.

15.

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.

Champiat S, Raposo RA, Maness NJ, Lehman JL, Purtell SE, Hasenkrug AM, Miller JC, Dean H, Koff WC, Hong MA, Martin JN, Deeks SG, Spotts GE, Pilcher CD, Hecht FM, Kallas EG, Garrison KE, Nixon DF.

PLoS One. 2012;7(6):e39311. doi: 10.1371/journal.pone.0039311. Epub 2012 Jun 29.

16.

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.

Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20166-71. doi: 10.1073/pnas.1110064108. Epub 2011 Nov 30.

17.

DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Yewdell JW.

Trends Immunol. 2011 Nov;32(11):548-58. doi: 10.1016/j.it.2011.08.001. Epub 2011 Sep 29. Review.

18.

CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.

Cardinaud S, Consiglieri G, Bouziat R, Urrutia A, Graff-Dubois S, Fourati S, Malet I, Guergnon J, Guihot A, Katlama C, Autran B, van Endert P, Lemonnier FA, Appay V, Schwartz O, Kloetzel PM, Moris A.

PLoS Pathog. 2011 May;7(5):e1002049. doi: 10.1371/journal.ppat.1002049. Epub 2011 May 12.

19.

Non-conventional sources of peptides presented by MHC class I.

Starck SR, Shastri N.

Cell Mol Life Sci. 2011 May;68(9):1471-9. doi: 10.1007/s00018-011-0655-0. Epub 2011 Mar 10. Review.

20.

Impaired memory CD8 T cell responses against an immunodominant retroviral cryptic epitope.

Rutkowski MR, Stevens CA, Green WR.

Virology. 2011 Apr 10;412(2):256-68. doi: 10.1016/j.virol.2010.11.013. Epub 2011 Feb 4.

Supplemental Content

Support Center